medeuronet exhibits at the Journées de Réflexions Ophtalmologiques (JRO) in Paris. ...November 26, 2014
“ One company, with three areas of expertise,
each with dedicated leadership & resources –
delivering a continuum of solutions.”
“ We share your drive to make things better.
So we built a better way to get your medtech innovation
to the right people in Europe.”
We guide your medtech innovation through the entire medtech lifecycle.
Whether an established or a start-up company, you need one partner that can guide you.
medeuronet played a part in two of the biggest exits in ophthalmology in the past 10 years – WaveTec Vision Systems and IntraLase.
The path is the same for any medical device. We bring focus, consistency and efficiency to the commercialization process.
A controlled process. The best way to change a market is to correctly target, prove your value, then expand.
We get your technology into the right hands at the right time, with expert training and support.
“ medeuronet played a part
in two of the biggest exits in ophthalmology in the past 10 years –
WaveTec and IntraLase. ”
WaveTec was acquired by Alcon/Novartis in October 2014. medeuronet worked with WaveTec from 2007, assisting with communication and market launch to EU commercial introduction and acquisition.
IntraLase was acquired by Abbott for almost a billion dollars; here medeuronet’s medical communication team helped power the marketing story that saw the IntraLase Femtosecond Laser change the refractive surgery laser market.
With TearLab Corporation, medeuronet worked with the company to set-up TearLab’s groundbreaking Core Validation Study – a 6-center European study that demonstrated the benefit of an objective test for dry eye disease.
(Europe outside the UK)
medeuronet’s network provides our clients with robust expertise in the key areas of reimbursement, regulatory and clinical study management along with a country commercial network that ensures consistent market introduction.
The latest news from medeuronet